🇺🇸 FDA
Pipeline program

ATH434 dose level 1

ATH434-201

Phase 2 small_molecule completed

Quick answer

ATH434 dose level 1 for Multiple System Atrophy is a Phase 2 program (small_molecule) at ALTERITY THERAPEUTICS LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
ALTERITY THERAPEUTICS LTD
Indication
Multiple System Atrophy
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials